ReviewFrontiers in oncology2022

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy.

Adrian Chye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.